China Pharma Holdings, Inc. Reports Third Quarter 2008 Financial Results and Corpora...(in China's highlyfragmented pharmaceutic...),Health

Date:11/7/2008

in China's highly fragmented pharmaceutical market due to our high margin and low cost business model, which is supported by our scalable manufacturing infrastructure and diverse product portfolio based on market demand. Our near-term strategy is to maintain rapid growth by investing in marketing and promotional activities to increase sales and market share, expanding distribution, and developing competitive new products."

Recent and Upcoming Milestones

Clinical Trials of Novel Antibiotic Combination Approved by SFDA and Initiated

In November 2008, the Company initiated clinical trials of its novel antibiotic combination formula after the SFDA completed its technical analyses and cleared the product for clinical trials. The novel antibiotic combination is a third generation Cephalosporin antibiotic formulated with a bacterial- enzyme inhibitor for the treatment of infections. The inclusion of a bacterial-enzyme inhibitor gives it the potential to address antibiotic- resistant infections, which are on the rise in China.

AMEX Listing Plans Underway

The Company is confident that it meets AMEX listing requirements pending compliance with minimum bid price rules. During senior management's trip to the U.S., the team will continue to discuss listing preparations with specialists and advisors.

Two-Week U.S. Tour in November 2008 to Present at Conferences and Meet Investors

Ms. Zhilin Li, President and CEO, will visit the U.S. for the first time with senior management to meet investors and participate in two investor conferences. The U.S. tour will begin on November 10, 2008 in New York City, where management will present at Rodman and Renshaw's Annual Global Investment Conference. Management will visit investors in several other cities, including Los Angeles and San Francisco. The tour will conclude on November 21, 2008 in Las Vegas, Nevada, where management will present at Roth Capital's "China Comes to Vegas" conference. M
'/>"/>

SOURCE China Pharma Holdings, Inc. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10
Related medicine news :

1. China Pharma Holdings, Inc. to Host Third Quarter 2008 Earnings Conference Call at 10 a.m. EST Friday November 7, 2008
2. TomoTherapy Completes Acquisition of Linear Accelerator Manufacturer in China
3. China Nepstar Chain Drugstore to Announce Third Quarter 2008 Financial Results on November 26
4. China-Biotics, Inc. Announces Conference Call to Discuss Second Quarter 2009 Financial Results
5. China Sky One Medical, Inc. Obtains Production Approval for Two New Drugs
6. China Pharma Holdings, Inc. to Initiate Clinical Trials For New Antibiotic Combination
7. China Medical Technologies to Attend Credit Suisse Asian Healthcare Conference
8. China Sky One Medical, Inc. Acquires Drug to Treat Breast Lesions
9. Simcere Pharmaceutical Group to Participate in Goldman Sachs China Investment Frontier Conference 2008
10. China Sky One Medical, Inc. Receives Tax Refund
11. Mindray Medical to Exhibit New Products at 60th China International Medical Equipment Fair